• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福尼尔坏疽:微生物学特征及死亡风险因素:97例病例回顾

Fournier's Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases.

作者信息

Temoçin Fatih, Atilla Aynur, Kuruoğlu Tuba, Kamalı-Polat Ayfer

机构信息

Department of Clinical Microbiology and Infectious Diseases, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Department of General Surgery, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

出版信息

Infect Dis Clin Microbiol. 2023 Mar 11;5(1):13-22. doi: 10.36519/idcm.2023.177. eCollection 2023 Mar.

DOI:10.36519/idcm.2023.177
PMID:38633899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10985828/
Abstract

OBJECTIVE

Fournier's gangrene (FG) is a rare necrotizing fasciitis affecting genital and perianal areas. This study aimed to provide data on predicting factors, mortality rates, and factors affecting mortality in comparison of survivors and non-survivors in patients with FG.

MATERIALS AND METHODS

This study included a retrospective analysis of patients diagnosed with FG between 2008 and 2018.

RESULTS

A total of 97 patients with FG were included in this study. Of the patients, 72 (74%) were male. The mean age was 56.03±13.92 years, and the median was 57 (21-90). The mortality rate was 21.6%. The most frequently isolated microorganism from tissue and blood cultures was (43%-42%). The median Fournier's Gangrene Severity Index (FGSI) and Uludağ FGSI (UFGSI) scores were 4 (0-20) and 5 (1-22), respectively. In the univariate model, mortality risk increases 7.18 times (=0.001) in patients with two or more comorbidities, 1.31 times as the FGSI score increases (<0.001), 1.28 times as the UFGSI score increases (<0.001). When the cut-off value was set as 8 for the FGSI score, the sensitivity was 71.43%, and the specificity was 73.68%. The sensitivity was 73.43%, and the specificity was 75% when the cut-off value was set as 6 for the UFGSI score. In the univariate model, the mortality risk of those with hypotension was 6.07 times higher (=0.003); as the platelet count increased, mortality risk decreased (odds ratio [OR]=0.99; =0.02). The mortality risk of those hospitalized in the intensive care unit (ICU) was 16.5 times higher than those followed in the ward (<0.001). In the multivariate model, this ratio was 6.49.

CONCLUSION

We concluded that FGSI and UFGSI scores could be used to predict mortality. Management of FG requires a multidisciplinary approach. Empiric treatment should include carbapenems and be de-escalated once getting the culture results. Authors from different centers should report their experiences to help reveal the ideal treatment and evaluate the consequences.

摘要

目的

福尼尔坏疽(FG)是一种罕见的坏死性筋膜炎,累及生殖器和肛周区域。本研究旨在提供FG患者中预测因素、死亡率以及影响存活者与非存活者死亡率的因素的数据。

材料与方法

本研究纳入了2008年至2018年期间诊断为FG的患者的回顾性分析。

结果

本研究共纳入97例FG患者。其中,72例(74%)为男性。平均年龄为56.03±13.92岁,中位数为57岁(21 - 90岁)。死亡率为21.6%。组织和血培养中最常分离出的微生物是(43% - 42%)。福尼尔坏疽严重程度指数(FGSI)和乌鲁达格FGSI(UFGSI)评分的中位数分别为4(0 - 20)和5(1 - 22)。在单变量模型中,有两种或更多合并症的患者死亡风险增加7.18倍(=0.001),FGSI评分每增加1分死亡风险增加1.31倍(<0.001),UFGSI评分每增加1分死亡风险增加1.28倍(<0.001)。当FGSI评分的截断值设定为8时,敏感性为71.43%,特异性为73.68%。当UFGSI评分的截断值设定为6时,敏感性为73.43%,特异性为75%。在单变量模型中,低血压患者的死亡风险高6.07倍(=0.003);随着血小板计数增加,死亡风险降低(比值比[OR]=0.99;=0.02)。入住重症监护病房(ICU)的患者的死亡风险比在病房接受治疗的患者高16.5倍(<0.001)。在多变量模型中,该比值为6.49。

结论

我们得出结论,FGSI和UFGSI评分可用于预测死亡率。FG的管理需要多学科方法。经验性治疗应包括碳青霉烯类药物,并在获得培养结果后降级。不同中心的作者应报告他们的经验,以帮助揭示理想的治疗方法并评估后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10985828/1cb645949cf5/IDCM-5-1-177_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10985828/6e534075b270/IDCM-5-1-177_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10985828/1cb645949cf5/IDCM-5-1-177_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10985828/6e534075b270/IDCM-5-1-177_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb27/10985828/1cb645949cf5/IDCM-5-1-177_Figure2.jpg

相似文献

1
Fournier's Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases.福尼尔坏疽:微生物学特征及死亡风险因素:97例病例回顾
Infect Dis Clin Microbiol. 2023 Mar 11;5(1):13-22. doi: 10.36519/idcm.2023.177. eCollection 2023 Mar.
2
Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene.是否需要 Fournier 坏疽严重程度指数?用于预测 Fournier 坏疽患者结局的评分系统比较。
BJU Int. 2012 Nov;110(9):1359-65. doi: 10.1111/j.1464-410X.2012.11082.x. Epub 2012 Apr 11.
3
Comparative analysis of scoring systems for predicting mortality in Fournier gangrene: single center, 15 years experience.Fournier 坏疽患者死亡率预测评分系统的比较分析:单中心,15 年经验。
Updates Surg. 2024 Nov;76(7):2683-2692. doi: 10.1007/s13304-024-02021-z. Epub 2024 Oct 8.
4
Comparison of Mortality in Fournier's Gangrene with the Two Scoring Systems.Fournier坏疽两种评分系统的死亡率比较
J Coll Physicians Surg Pak. 2020 Jan;30(1):67-72. doi: 10.29271/jcpsp.2020.01.67.
5
Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier's gangrene: A multicenter study.FGSI和UFGSI评分系统对预测福尼尔坏疽患者死亡率的有效性:一项多中心研究。
Ulus Travma Acil Cerrahi Derg. 2017 Sep;23(5):389-394. doi: 10.5505/tjtes.2017.71509.
6
Low magnesium levels an important new prognostic parameter can be overlooked in patients with Fournier's gangrene: a multicentric study.低镁水平作为一个重要的新预后参数,在福尼尔坏疽患者中可能被忽视:一项多中心研究。
Int Urol Nephrol. 2015 Dec;47(12):1939-45. doi: 10.1007/s11255-015-1131-9. Epub 2015 Oct 22.
7
A different perspective for morbidity related to Fournier's gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier's gangrene?一种看待 Fournier 坏疽相关发病率的不同视角:哪种评分系统更能可靠预测 Fournier 坏疽幸存者对植皮和皮瓣的需求?
Int Urol Nephrol. 2019 Aug;51(8):1303-1311. doi: 10.1007/s11255-019-02188-0. Epub 2019 Jun 8.
8
Comparison of different scoring systems for outcome prediction in patients with Fournier's gangrene: experience with 50 patients.福尼尔坏疽患者预后预测不同评分系统的比较:50例患者的经验
Scand J Urol. 2014 Aug;48(4):393-9. doi: 10.3109/21681805.2014.886289. Epub 2014 Feb 12.
9
Evaluating prognostic indicators for in-hospital mortality in Fournier's gangrene: a 7-year study in a tertiary hospital.评价 Fournier 坏疽院内死亡率的预后指标:一家三级医院的 7 年研究。
Arch Ital Urol Androl. 2024 May 30;96(2):12387. doi: 10.4081/aiua.2024.12387.
10
The Value of Fournier's Gangrene Scoring Systems on Admission to Predict Mortality: A Systematic Review and Meta-Analysis.入院时福尼尔坏疽评分系统对预测死亡率的价值:一项系统评价和荟萃分析。
J Pers Med. 2023 Aug 22;13(9):1283. doi: 10.3390/jpm13091283.

引用本文的文献

1
Necrotizing Fasciitis by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli as the Initial Presentation of Hairy Cell Leukemia: A Case Report.产超广谱β-内酰胺酶大肠埃希菌引起的坏死性筋膜炎作为毛细胞白血病的首发表现:一例报告
Cureus. 2025 Jul 23;17(7):e88614. doi: 10.7759/cureus.88614. eCollection 2025 Jul.
2
Fournier's Gangrene Mortality Index (FGMI): A New Scoring System for Predicting Fournier's Gangrene Mortality.福尼尔坏疽死亡率指数(FGMI):一种预测福尼尔坏疽死亡率的新评分系统。
Diagnostics (Basel). 2024 Dec 5;14(23):2732. doi: 10.3390/diagnostics14232732.
3
National Study of Fournier Gangrene in Spain (2016-2021): Gender/Sex Differences in Mortality and Risks.

本文引用的文献

1
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence.细菌的抗药性:机制、进化与持续。
J Mol Evol. 2020 Jan;88(1):26-40. doi: 10.1007/s00239-019-09914-3. Epub 2019 Oct 28.
2
Fournier's gangrene: a modern analysis of predictors of outcomes.福尼尔坏疽:结局预测因素的现代分析
Transl Androl Urol. 2019 Aug;8(4):374-378. doi: 10.21037/tau.2019.03.09.
3
Fournier Gangrene: A Review for Emergency Clinicians.福尼尔坏疽:急诊临床医生综述
西班牙全国 Fournier 坏疽研究(2016-2021):死亡率和风险的性别差异。
Medicina (Kaunas). 2024 Sep 29;60(10):1600. doi: 10.3390/medicina60101600.
4
Comparative analysis of scoring systems for predicting mortality in Fournier gangrene: single center, 15 years experience.Fournier 坏疽患者死亡率预测评分系统的比较分析:单中心,15 年经验。
Updates Surg. 2024 Nov;76(7):2683-2692. doi: 10.1007/s13304-024-02021-z. Epub 2024 Oct 8.
J Emerg Med. 2019 Oct;57(4):488-500. doi: 10.1016/j.jemermed.2019.06.023. Epub 2019 Aug 28.
4
Fournier's Gangrene: 10-Year Experience of a Plastic Surgery and Burns Department at a Tertiary Hospital.福尼尔坏疽:一家三级医院整形外科与烧伤科的10年经验
Acta Med Port. 2019 May 31;32(5):368-374. doi: 10.20344/amp.11003.
5
Presentation and Diagnosis of Fournier Gangrene.福尼尔坏疽的临床表现与诊断
Urology. 2018 Apr;114:8-13. doi: 10.1016/j.urology.2017.10.031. Epub 2017 Nov 13.
6
Sepsis: A Review of Advances in Management.脓毒症:管理进展综述。
Adv Ther. 2017 Nov;34(11):2393-2411. doi: 10.1007/s12325-017-0622-8. Epub 2017 Oct 11.
7
Risk factors for mortality in fournier's gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI).综合医院 Fournier 坏疽患者死亡的风险因素:简化 Fournier 坏疽严重指数评分(SFGSI)的应用。
Int Braz J Urol. 2018 Jan-Feb;44(1):95-101. doi: 10.1590/S1677-5538.IBJU.2017.0193.
8
Is Thrombocytopenia an Early Prognostic Marker in Septic Shock?血小板减少症是否是感染性休克的早期预后标志物?
Crit Care Med. 2016 Apr;44(4):764-72. doi: 10.1097/CCM.0000000000001520.
9
Current concepts in the management of necrotizing fasciitis.坏死性筋膜炎治疗的当前概念
Front Surg. 2014 Sep 29;1:36. doi: 10.3389/fsurg.2014.00036. eCollection 2014.
10
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.美国传染病学会关于皮肤和软组织感染的诊断和管理实践指南:2014 年更新。
Clin Infect Dis. 2014 Jul 15;59(2):147-59. doi: 10.1093/cid/ciu296. Epub 2014 Jun 18.